期刊文献+

D二聚体定量检测在肺部疾病的意义 被引量:28

Significance of D-dimer concentration test in lung disease
在线阅读 下载PDF
导出
摘要 目的:通过对肺部疾病患者D二聚体的检测,探讨该指标与疾病的关系及意义。方法:患者组284例,各种肺部疾患均经临床确诊。对照组30例,为排除心脑血管疾病、糖尿病、高脂血症等疾病的健康人。Liatest免疫法D二聚体定量(D-dimer)用STAGO STA Compact全自动凝血仪检测。结果:慢性支气管炎D-dimer(1.14±0.92)μg/mL;肺炎(2.09±1.31)μg/mL;肺心病(1.34±1.04)μg/mL;肺栓塞(2.53±1.43)μg/mL;肺癌(2.26±1.24)μg/mL明显高于对照组(0.31±0.25)(P<0.01)。肺癌转移组(n=45)D-dimer明显高于肺癌局限组(n=74)(2.96±1.51)μg/mLvs(1.32±1.03)μg/mL,P<0.01。结论:肺部疾病患者均有不同程度继发纤溶亢进,肺栓塞和肺癌D-dimer高于其他肺部良性疾病。提示凝血及纤溶的异常在肺部炎性疾病及肿瘤的发生和发展中起重要的作用。Liatest法检测D-dimer具有快速、敏感和自动化的特点,有助于临床对肺栓塞患者的筛选。 Objective To explore the significance and the association between variations of D-dimer and lung disease.Methods There were 284 patients in the patient group including 52 chronic bronchitis,44 pneumonia,32 cor pulmonale,47 pulmonary embolism and 119 lung cancer.The other 30 healthy controls were as control group.D-dimer was detected in all patients and 30 healthy control with Liatest method.Results D-dimer concentration was significantly higher in the patients with distant metastasis than in those without metastasis(P〈0.01).Conclusion D-dimer concentration is abnormal in the above patients.It is indicated that there is an increase of D-dimer in patients with lung disease.It plays an important role in the screening of pulmonary embolism.
出处 《实用诊断与治疗杂志》 2008年第1期4-5,共2页 Journal of Practical Diagnosis and Therapy
关键词 慢性支气管炎 肺炎 肺心病 肺栓塞 肺癌 D二聚体 Chronic bronchitis pneumonia cor Pulmonale pulmonary embolism lung cancer D-dimer
  • 相关文献

参考文献12

  • 1Aujesky D, Hayoz D, Yersin B, et al. Exclusion of pulmonary embolism using C-reactive protein and D-dimer, A prospective comparison[J]. Thromb Haemost, 2003,90(6) : 1198-1203.
  • 2孙慧超,林红伍.血浆D-二聚体阴性的肺栓塞1例[J].现代中西医结合杂志,2002,11(17):1732-1732. 被引量:1
  • 3王明生,吕健,李明昌,王河,肖毅,谭丽玲,谢东晓.D-二聚体不高一定能完全除外肺栓塞吗?(附1例肺栓塞报道)[J].中国医药导刊,2003,5(3):201-201. 被引量:2
  • 4Schrecengost J E, LeGallo R D, Boyd J C, et al. Comparison of diagnostic accuracies in outpatients and hospitalized patients of Ddimer testing for the evaluation of suspected pulmonary embolism [J]. Clin Chem,2003,49(9) :1483-1490.
  • 5Kulstad E B, Kulstad C E, Lovell E O. A rapid quantitative turbimetrie d-dimer assay has high sensitivity for detection of pulmonary embolism in the ED[J]. Am J Emerg Med, 2004,22(2):111-114.
  • 6Cestari D M, Weine D M, Panageas K S, et al. Stroke in patients with cancer: incidence and etiology [J]. Neurology, 2004,62(11) :2025-2030.
  • 7Weitz I C, Israel V K, Waisman J R, et al. Chemotherapy- induced activation of hemostasis: effect of a low molecular weight heparin (dalteparin sodium) on plasma markers of hemostatie aetivation[J]. Thromb Haemost, 2002,88 (2) : 213- 220.
  • 8Pavey S J, Hawson G A, Marsh N A. Impact of the fibrinolytie enzyme system on prognosis and survival associated with nonsmall cell lung carcinoma[J]. Blood Coagul Fibrinolysis, 2001, 12(1) :51-58.
  • 9Unsal E, Atalay F, Atikcan S, et al. Prognostic significance of hemostatic parameters in patients with lung cancer[J]. Respir Med, 2004,98(2):93-98.
  • 10杨秀芝,郎波,杨如玺.溶栓治疗血压正常并右室功能不全的肺栓塞患者的临床观察[J].实用诊断与治疗杂志,2007,21(2):129-131. 被引量:7

二级参考文献37

  • 1申红恩,申利静,张海柱.慢性肺源性心脏病合并心力衰竭血清、痰中白细胞介素及C反应蛋白的临床意义[J].实用诊断与治疗杂志,2004,18(5):367-368. 被引量:6
  • 2徐和平,李建伟,陈莉,董建增.50例急性肺栓塞2周后小剂量溶栓和单纯抗凝疗效观察[J].实用诊断与治疗杂志,2006,20(2):88-89. 被引量:8
  • 3沈利汉,戴路明.急性肺栓塞的治疗:抗凝与溶栓[J].国际呼吸杂志,2006,26(3):216-219. 被引量:7
  • 4中华医学会呼吸病学分会.肺栓塞栓塞症诊断与治疗指南(草案)[M].,..
  • 5Galie N, Gorge C, Heroid C, et al. Guidelines on diagnosis and management of acute pulmonary embolism. Em Heart J, 2002;21 : 1301.
  • 6Becker DM, Philbrick JT, Bachhuber TL, et al. D - dimer testing in suspected venous thromboembolism: an update.Q J Med, 1997; 90:437 - 442.
  • 7Ashitani J, Mukae H, Arimura Y, et al. Elevated plasmap rocoagulant and fibrinolytic markers in patients with chronic obstructive pulmonary disease[J]. Intern Med, 2002,41 (3)181.
  • 8CooK N S, Ubben D. Fibrinogcn as a major risk in cardiovascular disease [J]. Trends Pharmacol Sci, 1990,11 (4) : 444.
  • 9Ernst E. Fibrinogen: an important risk factor for atherothrombotic diseases [J]. Ann Med, 1994, 26 (1) : 15.
  • 10Danl M, Tybjaerg Hansen A, Vestbo J, et al. Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2001, 15,164(6):1008.

共引文献49

同被引文献268

引证文献28

二级引证文献222

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部